15
Views
8
CrossRef citations to date
0
Altmetric
Review

The therapeutic potential of islet cell transplant in the treatment of diabetes

Pages 785-795 | Published online: 23 Feb 2005

Bibliography

  • CRYER PE: Regulation of glucose metabolism in man. J. Int. Med. Suppl. (1991) 195:31–39.
  • REBRIN K, STEIL GM, GETTY L, BERGMAN RN: Free fatty acid as a link in the regulation of hepatic glucose out-put by peripheral insulin. Diabetes (1995) 44:1038–1045.
  • THE EXPERT COMMITTEE ON THE DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 20:1183–1197.
  • CARO JF, DOHM LG, PORIES WJ, SINHA MK: Cellular al-terations in liver, skeletal muscle and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes/Metabol. Rev. (1989) 5:665–689.
  • DEFRONZO RA: The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes (1988) 37:667–687.
  • OPARA EC, PETRO A, TEVRIZIAN A, FEINGLOS MN, SUR-WIT RS: L-Glutamine supplementation of a high-fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. J. Nutr. (1996) 126:273–279.
  • STORLIEN LH, BAUR LA, KRIKETOS AD et al.: Dietary fatsand insulin action. Diabetologia (1996) 39:621–631.
  • RUBIN RJ, ALTMAN WM, MENDELSON DN: Health careexpenditures for people with diabetes mellitus, 1992. Clin. Endocrinol. Metabol (1994) 78:809A–809F.
  • HARRIS MI: Descriptive Epidemiology Diabetes in America(2nd Edition). NIDDK, National Institutes of Health, Be-thesda, MD, USA (1995) 1.
  • THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. (1993) 329:977–986.
  • ALEJANDRO R, LEHMANN R, RICORDI C et al.: Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes (1997) 46: 1983-1989.
  • BRUNICARDI FC, MULLEN Y: Issues in clinical islet transplantation. Pancreas (1994) 9:281–290.
  • KENDALL DM, ROBERTSON RP: Pancreas and islet trans-plantation. Challenges for the twenty-first century. Curr. Therap. Diabetes (1997) 26:611–629.
  • WEIR GC, BONNER-WEIR S: Scientific and political im-pediments to successful islet transplantation. Diabetes (1997) 46:1247–1256.
  • SECCHI A, DI CARLO V, POZZA G: Pancreas and islet transplantation: current progresses, problems and perspectives. Horm. Metabol Res. (1997) 29:1–8.
  • PYKE D: Pancreas transplantation. Diabetes/Metab. Rev. (1991) 7:3–14.
  • GOSS JA, FLYE WM, LACY PE: Induction of allogeneic is-let survival by intrahepatic islet preimmunization and transient immunosuppression. Diabetes (1996) 45:144–147.
  • JANJIC D, ANDEREGGEN E, DENG S et al.: Improved insu-lin secretion of cryopreserved human islets by anti-oxidant treatment. Pancreas (1996) 13:166–172.
  • RAJOTTE RV, LAKEY JRT, WARNOCK GL: Adult islet cryo-preservation. In: Methods in Cell Transplantation. Ricordi C (Ed.), Landres, Austin, TX (1994):517–524.
  • TZE WJ, TAI J: Successful banking of pancreatic endo-crine cells for transplantation. Metabolism (1990) 39:719–723.
  • RICH SJ, SWIFT S, THIRDBOROUGH SM et al.: Islet cryo-preservation: a detailed study of total functional losses. Transplant Proc. (1994) 26:823–824.
  • FIELD J, FARNEY A, SUTHERLAND DER: Improved islet isolation from rat pancreas using 35% bovine serum albumin in combination with dextran gradient separa-tion. Transplantation (1996) 61:1554–1556.
  • LINETSKY E, BOTTINO R, LEHMANN R et al.: Improved human islet isolation using a new enzyme blend, lib-erase. Diabetes (1997) 46:1120–1123.
  • LITTMAN ED, OPARA EC, AKWARI OE: Glutathione-mediated preservation and enhancement of isolated perifused islet function. J. Surg. Res. (1995) 59:694–698.
  • OGAWA Y, NOMA Y, DAVALLI AM et al.: Loss of glucose-induced insulin secretion and GLUT2 expression in transplanted B-cells. Diabetes (1995) 44:75–79.
  • NACHER V, MERINO JF, RAURELL M, SOLER J, MONTANYA E: Normoglycemia restores B-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia. Diabetes (1998) 47:192–196.
  • SECCHI A, SOCCI C, MAFFI P et al.: Islet transplantation in IDDM patients. Diabetologia (1997) 40:225–231.
  • LIM F, SUN AM: Microencapsulated islets as bioartificial endocrine pancreas. Science (1980) 210:908–910.
  • O'SHEA GM, GOOSEN MFA, SUN AM: Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim. Biophys. Acta (1984) 804:133–136.
  • O'SHEA GM, SUN AM: Encapsulation of rat islets of Lan-gerhans prolongs xenograft survival in diabetic mice. Diabetes (1986) 35:943–946.
  • PETRUZZO P, PIBRI L, DE GIUDICI MA et al.: Xenotrans-plantation of microencapsulated pancreatic islets con-tained in a vascular prosthesis: preliminary results. Transplant Int. (1991) 4:200–204.
  • WOLTERS GHJ, FRITSCHY WM, GERRITS D, VAN SCHILF-GAARDE R: A versatile alginate droplet generator appli-cable for microencapsulation of pancreatic islets. J. Appl. Biomaterials (1992) 3:281–286.
  • ARRAJAB A, BENGMARK S, AHREN B: Insulin secretion in streptozotocin-diabetic rats transplanted with im-munoisolated islets. Transplantation (1991) 51:570–574.
  • SOON-SHIONG P, HEINTZ RE, MEREDITH N et al.: Insulin independence in type 1 diabetic patient after encapsu-lated islet transplantation. Lancet (1994) 343:950–951.
  • SUN Y, MAX, ZHOU D, VACEK I, SUN AM: Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. (1996) 98:1417–1422.
  • DARQUY S, REACH G: Immunoisolation of pancreatic B cells by microencapsulation: an in vitro study. Diabe-tologia (1985) 28:776–780.
  • EISENBARTH GS, STEGALL M: Islet and pancreatic trans-plantation - autoimmunity and alloimmunity. New Engl. J. Med. (1996) 335:888–889.
  • GARFINKEL M, HARLAND RC, OPARA EC: Optimization of the microencapsulated islet for transplantation. J. Surg. Res. (1998) 76. (In Press.)
  • CHARLES K, HARLAND RC, OPARA EC: Viability of cul-tured microencapsulated islets for transplantation. J. Invest. Med. (1998). (In Press.)
  • FRITSCHY WM, WOLTERS GHJ, VAN SCHILFGAARDE R: Effect of alginate-polylysine-alginate microencapsula-tion on in vitro insulin release from rat pancreatic is-lets. Diabetes (1991) 40:37–43.
  • VAN SUYLICHEM PTR, STRUBBE JH, HOMING H, WOL-TERS GHJ, VAN SCHILFGAARDE R: Insulin secretion by rat islet isografts of a defined endocrine volume after transplantation to three different sites. Diabetologia (1992) 35:917–923.
  • DE VOS P, VEGTER D, DE HAAN BJ et al.: Kinetics ofintraperitonally infused insulin in rats. Functional im-plications for bioartificial pancreas. Diabetes (1996) 45:1102–1107.
  • DIZEREGA GS, RODGERS KE: The Peritoneum. Springer-Verlag, New York (1992):1–10.
  • DAVALLI AM, SCAGLIA L, ZANGEN DH et al.: Vulnerabil-ity of islets in the immediate posttransplantation pe-riod. Dynamic changes in structure and function. Diabetes (1996) 45:1161–1167.
  • SOON-SHIONG P, OTTERLEI M, SKJAK-BRAEK G et al.: Animmunologic basis for the fibrotic reaction to im-planted microcapsules. Transplant Proc. (1991) 23:758–759.
  • MICHAELS MG, SIMMONS RL: Xenotransplantation-associated zoonoses. Strategies for prevention. Trans-plantation (1994) 57:1–7.
  • MORRIS PJ: Pig transplants postponed until we know more about graft rejection, physiology and infectivity. Br. Med. J. (1997) 314:242.
  • VOGEL G: No moratorium on clinical trials. Science(1998) 279:648.
  • PATIENCE C, TAKEUCHI Y, WEISS RA: Infection of hu-man cells by an endogenous retrovirus of pigs. Nature Med. (1997) 3:282–286.
  • GROTH CG, KORSGREN 0, TIBELL A et al.: Transplanta-tion of porcine fetal pancreas to diabetic patients. Lan-cet (1994) 344:1402–1404.
  • AR'RAJAB A, DAWIDSON IJA, HARRIS RB, SENTEMENTESJT: Effect of the number of islets on outcome after transplantation in streptozotocin-induced diabetic rats. Horm. Metab. Res. (1994) 26:355–359.
  • PETRUZZO P, CAPPAI A, DESSY E, RESCIGNO A, BROTZUG: Future of the microencapsulation procedure in islet transplantation. Acta Diabetologica (1997) 34:161.
  • WANG XG, TAFRA L, BEREZNIAK R et al.: Effects of co-transplantated fetal liver on fetal pancreas isografts. Transplantation (1991) 53:272–276.
  • THOMAS F, PITTMAN K, LJUNG T, CEKADA E: Deox-yspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts. Transplant. Proc. (1995) 27:417–419.
  • TROPPMANN C, GRUESSNER AC, PAPALOIS BE, NAKHLEH RE, GRUESSNER RWG: Discordant xenoislets from large animal donor undergo accelerated graft failure rather than hyperacute rejection: impact of im-munosuppression, islet mass and transplant site on early outcome. Surgery (1997) 121:194-205. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(5)
  • POWERS AC, BRISSOVA M, LACIK I et al.: Permeability as-sessment of capsules for islet transplantation. Ann. NY Acad. (1997) 831:208–216.
  • SIEBERS U, HORCHER A, BRETZEL RG, FEDERLIN K, ZEKORN T: Alginate-based microcapsules for immuno-protected islet transplantation. Ann. NY Acad. (1997) 831:304-312. Emmanuel C Opara

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.